Intracellular localization of titanium within xenografted sensitive human tumors after treatment with the antitumor agent titanocene dichloride
- PMID: 2100149
- DOI: 10.1016/1047-8477(90)90096-u
Intracellular localization of titanium within xenografted sensitive human tumors after treatment with the antitumor agent titanocene dichloride
Abstract
In the present study, the intracellular localization of titanium was analyzed in three xenografted human adenocarcinomas of the colon sigmoideum (S 90), the stomach (M-Stg 4), and the lung (L 261) in dependence on the time after application of a single therapeutic dose (80 mg/kg) of the organometallic antitumor agent titanocene dichloride (C5H5)2TiCl2. The investigations were performed by use of electron energy loss spectroscopy (EELS), a method which allows microanalysis in ultrathin sections, in combination with electron spectroscopic imaging (ESI), which offers the possibility to image the two-dimensional localization and distribution of light- and medium-weight elements in animal tissues. In all three tumors which were studied, titanium was at first detected within the nucleus and, some hours and days later, it was additionally found in cytoplasmic lysosomes. In the colon and lung tumors S 90 and L 261, already 12 hr after treatment, titanium was traceable as tender granules in the nuclear chromatin. During the following days, it was then accumulated in certain areas of the nuclear heterochromatin and, in the case of the L 261 tumor, also in the nucleolus. Maximum concentrations were attained in the nuclei and nucleoli at 48 hr after substance application. Thereafter, titanium was increasingly incorporated into cytoplasmic lysosomes which are known to be involved in intracellular degrading and digesting processes and which occurred in increased numbers in treated tumor cells. Regarding the stomach carcinoma M-Stg 4, titanium was recognized in the nuclear heterochromatin only 1 and 2 days after application of titanocene dichloride. At 48 hr, it was additionally detected in cytoplasmic lysosomes. In all cases where titanium was found accumulated in the nucleus and in lysosomes, phosphorus was simultaneously enriched in a similar local distribution and a concentration which even exceeded that within phosphorus-rich areas, e.g., the nuclear heterochromatin and cytoplasmic ribosomes. These results confirm a primary interaction of titanium-containing metabolites deriving from titanocene complexes with nucleic acid molecules, especially with nuclear DNA. They suggest the formation of aggregates between nucleic acids and titanium-containing metabolites which are obviously extruded out of the nuclei and incorporated into cytoplasmic lysosomes, known to be involved in intracellular digesting processes.
Similar articles
-
Electron-spectroscopic imaging--a method for analysing the distribution of light elements in mammalian cells and tissues.Acta Histochem. 1991;91(1):25-37. doi: 10.1016/S0065-1281(11)80288-6. Acta Histochem. 1991. PMID: 1801512
-
Subcellular distribution of titanium in the liver after treatment with the antitumor agent titanocene dichloride. A study using electron spectroscopic imaging.Virchows Arch B Cell Pathol Incl Mol Pathol. 1989;57(4):213-22. doi: 10.1007/BF02899084. Virchows Arch B Cell Pathol Incl Mol Pathol. 1989. PMID: 2569781
-
Tumor inhibition by metallocenes: ultrastructural localization of titanium and vanadium in treated tumor cells by electron energy loss spectroscopy.Chem Biol Interact. 1983 Jun;44(3):317-28. doi: 10.1016/0009-2797(83)90059-5. Chem Biol Interact. 1983. PMID: 6872095
-
Antitumor titanium compounds.Mini Rev Med Chem. 2004 Jan;4(1):49-60. doi: 10.2174/1389557043487565. Mini Rev Med Chem. 2004. PMID: 14754443 Review.
-
Titanium and vanadium complexes as anticancer agents.Anticancer Agents Med Chem. 2009 Oct;9(8):827-42. doi: 10.2174/187152009789124646. Anticancer Agents Med Chem. 2009. PMID: 19538167 Review.
Cited by
-
Scope of organometallic compounds based on transition metal-arene systems as anticancer agents: starting from the classical paradigm to targeting multiple strategies.RSC Adv. 2019 Jan 24;9(6):3239-3278. doi: 10.1039/c8ra07926a. eCollection 2019 Jan 22. RSC Adv. 2019. PMID: 35518979 Free PMC article. Review.
-
Complexes of metals other than platinum as antitumour agents.Eur J Clin Pharmacol. 1994;47(1):1-16. doi: 10.1007/BF00193472. Eur J Clin Pharmacol. 1994. PMID: 7988618 Review.
-
Antitumor activity of titanocene amino acid complexes.Biometals. 1996 Jul;9(3):267-71. doi: 10.1007/BF00817926. Biometals. 1996. PMID: 8696077
-
Titanocene-phosphine derivatives as precursors to cytotoxic heterometallic TiAu2 and TiM (M = Pd, Pt) compounds. Studies of their interactions with DNA.Inorg Chem. 2011 Nov 7;50(21):11099-110. doi: 10.1021/ic201647h. Epub 2011 Sep 29. Inorg Chem. 2011. PMID: 21958150 Free PMC article.
-
Differential cytotoxicity induced by the Titanium(IV)Salan complex Tc52 in G2-phase independent of DNA damage.BMC Cancer. 2016 Jul 13;16:469. doi: 10.1186/s12885-016-2538-0. BMC Cancer. 2016. PMID: 27412346 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Medical